{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:46:08Z","timestamp":1782535568673,"version":"3.54.5"},"reference-count":37,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.1620\/tjem.2025.j091","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T22:07:51Z","timestamp":1752703671000},"page":"189-197","source":"Crossref","is-referenced-by-count":0,"title":["Drp1-Dependent Mitochondrial Fission is Involved in Adriamycin Resistance in Gastric Cancer Cells: A Perspective from the BATF2\/p53\/ERK Regulatory Axis"],"prefix":"10.1620","volume":"269","author":[{"given":"Wei","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal and Bariatric Metabolic Surgery, The First People\u2019s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The First People\u2019s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Bariatric Metabolic Surgery, The First People\u2019s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Bariatric Metabolic Surgery, The First People\u2019s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Bariatric Metabolic Surgery, The First People\u2019s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyan","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Bariatric Metabolic Surgery, The First People\u2019s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Bariatric Metabolic Surgery, The First People\u2019s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Bariatric Metabolic Surgery, The First People\u2019s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Bariatric Metabolic Surgery, The First People\u2019s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"Ajani, J.A., D&apos;Amico, T.A., Bentrem, D.J., Chao, J., Cooke, D., Corvera, C., Das, P., Enzinger, P.C., Enzler, T., Fanta, P., Farjah, F., Gerdes, H., Gibson, M.K., Hochwald, S., Hofstetter, W.L., et al. (2022)  Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. <i>J. Natl. Compr. Canc. Netw.<\/i>, 20, 167-192. https:\/\/doi.org\/10.6004\/jnccn.2022.0008","DOI":"10.6004\/jnccn.2022.0008"},{"key":"2","doi-asserted-by":"publisher","unstructured":"Cao, L., Weng, K., Li, L., Lin, G., Zhao, Y., Gao, Y., Huang, X., Chen, Q., Wang, J., Zheng, C., Huang, C., Xie, J.&amp;Li, P. (2024)  BATF2 inhibits the stem cell-like properties and chemoresistance of gastric cancer cells through PTEN\/AKT\/beta-catenin pathway. <i>Theranostics<\/i>, 14, 7007-7022. https:\/\/doi.org\/10.7150\/thno.98389","DOI":"10.7150\/thno.98389"},{"key":"3","doi-asserted-by":"publisher","unstructured":"Chang, Y.Y., Wang, M., Yeh, J.H., Tsou, S.C., Chen, T.C., Hsu, M.Y., Lee, Y.J., Wang, I.&amp;Lin, H.W. (2023)  The protective effects of beta-mangostin against sodium iodate-induced retinal ROS-mediated apoptosis through MEK\/ERK and p53 signaling pathways. <i>Food Funct.<\/i>, 14, 10896-10909. https:\/\/doi.org\/10.1039\/d3fo03568a","DOI":"10.1039\/D3FO03568A"},{"key":"4","doi-asserted-by":"publisher","unstructured":"Chen, P., Lu, Y., He, B., Xie, T., Yan, C., Liu, T., Wu, S., Yeh, Y., Li, Z., Huang, W.&amp;Zhang, X. (2023)  Rab32 promotes glioblastoma migration and invasion via regulation of ERK\/Drp1-mediated mitochondrial fission. <i>Cell Death Dis.<\/i>, 14, 198. https:\/\/doi.org\/10.1038\/s41419-023-05721-3","DOI":"10.1038\/s41419-023-05721-3"},{"key":"5","doi-asserted-by":"publisher","unstructured":"Chu, Y., Xiao, Z., Jing, N., Yan, W., Wang, S., Ma, B., Zhang, J.&amp;Li, Y. (2021)  Arborinine, a potential LSD1 inhibitor, inhibits epithelial-mesenchymal transition of SGC-7901 cells and adriamycin-resistant gastric cancer SGC-7901\/ADR cells. <i>Invest. New Drugs<\/i>, 39, 627-635. https:\/\/doi.org\/10.1007\/s10637-020-01016-y","DOI":"10.1007\/s10637-020-01016-y"},{"key":"6","doi-asserted-by":"publisher","unstructured":"Dash, R., Bhoopathi, P., Das, S.K., Sarkar, S., Emdad, L., Dasgupta, S., Sarkar, D.&amp;Fisher, P.B. (2014)  Novel mechanism of MDA-7\/IL-24 cancer-specific apoptosis through SARI induction. <i>Cancer Res.<\/i>, 74, 563-574. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1062","DOI":"10.1158\/0008-5472.CAN-13-1062"},{"key":"7","doi-asserted-by":"publisher","unstructured":"Ding, R., Wang, Y., Xu, L., Sang, S., Wu, G., Yang, W., Zhang, Y., Wang, C., Qi, A., Xie, H., Liu, Y., Dai, A.&amp;Jiao, L. (2024)  QiDongNing induces lung cancer cell apoptosis via triggering P53\/DRP1-mediated mitochondrial fission. <i>J. Cell. Mol. Med.<\/i>, 28, e18353. https:\/\/doi.org\/10.1111\/jcmm.18353","DOI":"10.1111\/jcmm.18353"},{"key":"8","doi-asserted-by":"publisher","unstructured":"Feng, W., Wang, J., Yan, X., Zhang, Q., Chai, L., Wang, Q., Shi, W., Chen, Y., Liu, J., Qu, Z., Li, S., Xie, X.&amp;Li, M. (2021)  ERK\/Drp1-dependent mitochondrial fission contributes to HMGB1-induced autophagy in pulmonary arterial hypertension. <i>Cell Prolif.<\/i>, 54, e13048. https:\/\/doi.org\/10.1111\/cpr.13048","DOI":"10.1111\/cpr.13048"},{"key":"9","doi-asserted-by":"publisher","unstructured":"Guan, W.L., He, Y.&amp;Xu, R.H. (2023)  Gastric cancer treatment: recent progress and future perspectives. <i>J. Hematol. Oncol.<\/i>, 16, 57. https:\/\/doi.org\/10.1186\/s13045-023-01451-3","DOI":"10.1186\/s13045-023-01451-3"},{"key":"10","doi-asserted-by":"publisher","unstructured":"Han, Y., Kim, B., Cho, U., Park, I.S., Kim, S.I., Dhanasekaran, D.N., Tsang, B.K.&amp;Song, Y.S. (2019)  Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells. <i>Oncogene<\/i>, 38, 7089-7105. https:\/\/doi.org\/10.1038\/s41388-019-0949-5","DOI":"10.1038\/s41388-019-0949-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Hou, W., Zhao, Y.&amp;Zhu, H. (2023)  Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects. <i>Int. J. Mol. Sci.<\/i>, 24, 15321. https:\/\/doi.org\/10.3390\/ijms242015321","DOI":"10.3390\/ijms242015321"},{"key":"12","doi-asserted-by":"publisher","unstructured":"Jiang, Q., Chen, Z., Meng, F., Zhang, H., Chen, H., Xue, J., Shen, X., Liu, T., Dong, L., Zhang, S.&amp;Xue, R. (2023)  CD36-BATF2\\MYB Axis Predicts Anti-PD-1 Immunotherapy Response in Gastric Cancer. <i>Int. J. Biol. Sci.<\/i>, 19, 4476-4492. https:\/\/doi.org\/10.7150\/ijbs.87635","DOI":"10.7150\/ijbs.87635"},{"key":"13","doi-asserted-by":"publisher","unstructured":"Jin, P., Jiang, J., Zhou, L., Huang, Z., Nice, E.C., Huang, C.&amp;Fu, L. (2022)  Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. <i>J. Hematol. Oncol.<\/i>, 15, 97. https:\/\/doi.org\/10.1186\/s13045-022-01313-4","DOI":"10.1186\/s13045-022-01313-4"},{"key":"14","doi-asserted-by":"publisher","unstructured":"Li, B., Wang, W., Li, Z., Chen, Z., Zhi, X., Xu, J., Li, Q., Wang, L., Huang, X., Wang, L., Wei, S., Sun, G., Zhang, X., He, Z., Zhang, L., et al. (2017)  MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression. <i>Cancer Lett.<\/i>, 410, 212-227. https:\/\/doi.org\/10.1016\/j.canlet.2017.09.035","DOI":"10.1016\/j.canlet.2017.09.035"},{"key":"15","doi-asserted-by":"publisher","unstructured":"Li, Y., Fan, L., Yan, A., Ren, X., Zhao, Y.&amp;Hua, B. (2024)  Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1\/ERK pathway. <i>J. Transl. Med.<\/i>, 22, 112. https:\/\/doi.org\/10.1186\/s12967-024-04914-4","DOI":"10.1186\/s12967-024-04914-4"},{"key":"16","doi-asserted-by":"publisher","unstructured":"Lin, W., Miao, Y., Meng, X., Huang, Y., Zhao, W.&amp;Ruan, J. (2020)  miRNA-765 mediates multidrug resistance via targeting BATF2 in gastric cancer cells. <i>FEBS Open Bio<\/i>, 10, 1021-1030. https:\/\/doi.org\/10.1002\/2211-5463.12838","DOI":"10.1002\/2211-5463.12838"},{"key":"17","doi-asserted-by":"publisher","unstructured":"Liu, J., Mao, W., Ding, B.&amp;Liang, C.S. (2008)  ERKs\/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, 295, H1956-1965. https:\/\/doi.org\/10.1152\/ajpheart.00407.2008","DOI":"10.1152\/ajpheart.00407.2008"},{"key":"18","doi-asserted-by":"publisher","unstructured":"Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R.&amp;Sitarz, R. (2020)  Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. <i>Int. J. Mol. Sci.<\/i>, 21, 4012. https:\/\/doi.org\/10.3390\/ijms21114012","DOI":"10.3390\/ijms21114012"},{"key":"19","doi-asserted-by":"publisher","unstructured":"Meinag, F.E., Fatahi, M., Vahedian, V., Maroufi, N.F., Mosayyebi, B., Ahmadi, E.&amp;Rahmati, M. (2024)  Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view. <i>Funct. Integr. Genomics<\/i>, 24, 150. https:\/\/doi.org\/10.1007\/s10142-024-01431-x","DOI":"10.1007\/s10142-024-01431-x"},{"key":"20","doi-asserted-by":"publisher","unstructured":"Niu, K., Chen, Z., Li, M., Ma, G., Deng, Y., Zhang, J., Wei, D., Wang, J.&amp;Zhao, Y. (2025)  NSUN2 lactylation drives cancer cell resistance to ferroptosis through enhancing GCLC-dependent glutathione synthesis. <i>Redox Biol.<\/i>, 79, 103479. https:\/\/doi.org\/10.1016\/j.redox.2024.103479","DOI":"10.1016\/j.redox.2024.103479"},{"key":"21","doi-asserted-by":"publisher","unstructured":"R\u00f6cken, C.(2023)  Predictive biomarkers in gastric cancer. <i>J. Cancer Res. Clin. Oncol.<\/i>, 149, 467-481. https:\/\/doi.org\/10.1007\/s00432-022-04408-0","DOI":"10.1007\/s00432-022-04408-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Romani, P., Nirchio, N., Arboit, M., Barbieri, V., Tosi, A., Michielin, F., Shibuya, S., Benoist, T., Wu, D., Hindmarch, C.C.T., Giomo, M., Urciuolo, A., Giamogante, F., Roveri, A., Chakravarty, P., et al. (2022)  Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance. <i>Nat. Cell Biol.<\/i>, 24, 168-180. https:\/\/doi.org\/10.1038\/s41556-022-00843-w","DOI":"10.1038\/s41556-022-00843-w"},{"key":"23","doi-asserted-by":"publisher","unstructured":"Sexton, R.E., Al Hallak, M.N., Diab, M.&amp;Azmi, A.S. (2020)  Gastric cancer: a comprehensive review of current and future treatment strategies. <i>Cancer Metastasis Rev.<\/i>, 39, 1179-1203. https:\/\/doi.org\/10.1007\/s10555-020-09925-3","DOI":"10.1007\/s10555-020-09925-3"},{"key":"24","doi-asserted-by":"publisher","unstructured":"Smyth, E.C., Nilsson, M., Grabsch, H.I., van Grieken, N.C.&amp;Lordick, F. (2020)  Gastric cancer. <i>Lancet<\/i>, 396, 635-648. https:\/\/doi.org\/10.1016\/S0140-6736(20)31288-5","DOI":"10.1016\/S0140-6736(20)31288-5"},{"key":"25","doi-asserted-by":"publisher","unstructured":"Wang, J.X., Li, Q.&amp;Li, P.F. (2009)  Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1. <i>Cancer Res.<\/i>, 69, 492-500. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2962","DOI":"10.1158\/0008-5472.CAN-08-2962"},{"key":"26","doi-asserted-by":"publisher","unstructured":"Wen, H., Tang, J., Cui, Y., Hou, M.&amp;Zhou, J. (2023)  m6A modification-mediated BATF2 suppresses metastasis and angiogenesis of tongue squamous cell carcinoma through inhibiting VEGFA. <i>Cell Cycle<\/i>, 22, 100-116. https:\/\/doi.org\/10.1080\/15384101.2022.2109897","DOI":"10.1080\/15384101.2022.2109897"},{"key":"27","doi-asserted-by":"publisher","unstructured":"Xiao, Y.Y., Xiao, J.X., Wang, X.Y., Wang, T., Qu, X.H., Jiang, L.P., Tou, F.F., Chen, Z.P.&amp;Han, X.J. (2022)  Metformin-induced AMPK activation promotes cisplatin resistance through PINK1\/Parkin dependent mitophagy in gastric cancer. <i>Front. Oncol.<\/i>, 12, 956190. https:\/\/doi.org\/10.3389\/fonc.2022.956190","DOI":"10.3389\/fonc.2022.956190"},{"key":"28","doi-asserted-by":"publisher","unstructured":"Xie, J.W., Huang, X.B., Chen, Q.Y., Ma, Y.B., Zhao, Y.J., Liu, L.C., Wang, J.B., Lin, J.X., Lu, J., Cao, L.L., Lin, M., Tu, R.H., Zheng, C.H., Huang, C.M.&amp;Li, P. (2020a)  m(6)A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling. <i>Mol. Cancer<\/i>, 19, 114. https:\/\/doi.org\/10.1186\/s12943-020-01223-4","DOI":"10.1186\/s12943-020-01223-4"},{"key":"29","doi-asserted-by":"publisher","unstructured":"Xie, L., Shi, F., Li, Y., Li, W., Yu, X., Zhao, L., Zhou, M., Hu, J., Luo, X., Tang, M., Fan, J., Zhou, J., Gao, Q., Wu, W., Zhang, X., et al. (2020b)  Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. <i>Signal Transduct. Target. Ther.<\/i>, 5, 56. https:\/\/doi.org\/10.1038\/s41392-020-0151-9","DOI":"10.1038\/s41392-020-0151-9"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Xu, J., Liu, D., Niu, H., Zhu, G., Xu, Y., Ye, D., Li, J.&amp;Zhang, Q. (2017)  Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN\/Akt signaling pathway in gastric cancer. <i>J. Exp. Clin. Cancer Res.<\/i>, 36, 19. https:\/\/doi.org\/10.1186\/s13046-016-0487-8","DOI":"10.1186\/s13046-016-0487-8"},{"key":"31","doi-asserted-by":"publisher","unstructured":"Yang, W., Wu, B., Ma, N., Wang, Y., Guo, J., Zhu, J.&amp;Zhao, S. (2019a)  BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt\/beta-catenin signaling. <i>In Vitro Cell. Dev. Biol. Anim.<\/i>, 55, 445-452. https:\/\/doi.org\/10.1007\/s11626-019-00360-5","DOI":"10.1007\/s11626-019-00360-5"},{"key":"32","doi-asserted-by":"publisher","unstructured":"Yang, W., Zhao, S., Wu, B., Xu, J., Wu, Z., Guo, J.&amp;Zeng, R. (2019b)  BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells. <i>Cancer Chemother. Pharmacol.<\/i>, 84, 1279-1288. https:\/\/doi.org\/10.1007\/s00280-019-03958-4","DOI":"10.1007\/s00280-019-03958-4"},{"key":"33","doi-asserted-by":"publisher","unstructured":"Yang, W.J., Zhao, H.P., Yu, Y., Wang, J.H., Guo, L., Liu, J.Y., Pu, J.&amp;Lv, J. (2023)  Updates on global epidemiology, risk and prognostic factors of gastric cancer. <i>World J. Gastroenterol.<\/i>, 29, 2452-2468. https:\/\/doi.org\/10.3748\/wjg.v29.i16.2452","DOI":"10.3748\/wjg.v29.i16.2452"},{"key":"34","doi-asserted-by":"publisher","unstructured":"Yang, X., Zeng, J., Jiang, C., Zhang, Y.&amp;Zhang, X. (2024)  Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway. <i>Rev. Invest. Clin.<\/i>, 76, 6-17. https:\/\/doi.org\/10.24875\/RIC.23000180","DOI":"10.24875\/RIC.23000180"},{"key":"35","doi-asserted-by":"publisher","unstructured":"Zhang, X., Liu, Y., Dai, L., Shi, G., Deng, J., Luo, Q., Xie, Q., Cheng, L., Li, C., Lin, Y., Wang, Q., Fan, P., Zhang, H., Su, X., Zhang, S., et al. (2021)  BATF2 prevents glioblastoma multiforme progression by inhibiting recruitment of myeloid-derived suppressor cells. <i>Oncogene<\/i>, 40, 1516-1530. https:\/\/doi.org\/10.1038\/s41388-020-01627-y","DOI":"10.1038\/s41388-020-01627-y"},{"key":"36","doi-asserted-by":"publisher","unstructured":"Zhang, X., Zhang, Q., Yu, M., Zhang, Y., He, T., Qiu, Z., Qiu, Y.&amp;Wang, W. (2024)  Integrating serum pharmacochemistry and network pharmacology to explore the molecular mechanisms of Acanthopanax senticosus (Rupr. &amp; Maxim.) Harms on attenuating doxorubicin-induced myocardial injury. <i>J. Ethnopharmacol.<\/i>, 319, 117349. https:\/\/doi.org\/10.1016\/j.jep.2023.117349","DOI":"10.1016\/j.jep.2023.117349"},{"key":"37","doi-asserted-by":"publisher","unstructured":"Zhou, J., Lei, Z., Chen, J., Liao, S., Chen, Y., Liu, C., Huang, S., Li, L., Zhang, Y., Wang, P., Huang, Y., Li, J.&amp;Liang, H. (2023)  Nuclear export of BATF2 enhances colorectal cancer proliferation through binding to CRM1. <i>Clin. Transl. Med.<\/i>, 13, e1260. https:\/\/doi.org\/10.1002\/ctm2.1260","DOI":"10.1002\/ctm2.1260"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/2\/269_2025.J091\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:11:36Z","timestamp":1782533496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/2\/269_2025.J091\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j091","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025.J091"}}